Number of patients | 7 | 42 | 38 |
Mean age at first pregnancy (years) | 24 (2) (19–27) | 26 (4) (18–33) | 24 (4) (16–36) |
Mean age at review (years) | 29 (6) (29–44) | 33 (7) (31–41) | 34 (3) (27–53) |
Angina | 2 (28.6%) | 10 (23.8%) | 10 (26.3%) |
Dyspnoea (NYHA ⩾II) | 1 (14.5%) | 9 (21.4%) | 11 (28.9%) |
Syncope | 0 (0%) | 4 (9.5%) | 5 (13.1%) |
Palpitations | 1 (14.3%) | 7 (16.7%) | 6 (15.8%) |
Ventricular tachycardia | 0 (0%) | 0 (0%) | 1 (2.6%) |
Non-sustained ventricular tachycardia | 0 (0%) | 6 (14.3%) | 4 (10.5%) |
Paroxysmal atrial fibrillation | 1 (14.3%) | 3 (7.1%) | 6 (15.8%) |
Atrial fibrillation | 0 (0%) | 1 (2.4%) | 4 (10.5%) |
FHSCD | 1 (14.3%) | 6 (14.3%) | 6 (15.8%) |
ABPR | 1 (14.3%) | 6 (14.3%) | 3 (7.9%) |
Mean %Vo2 max | 78 (16) (54–111) | 73 (9) (63–105) | 77 (12) (59–100) |
Mean MLVWT (mm) | 21 (4) (15–26) | 23 (5) (15–31) | 19 (3) (14–30) |
Mean LVED (mm) | 42 (3) (35–49) | 44 (4) (30–49) | 46 (5) (34–54) |
Mean LVES (mm) | 29 (3) (21–34) | 28 (5) (16–41) | 30 (6) (17–42) |
Mean fractional shortening (%) | 32 (7) (29–47) | 36 (6) (28–52) | 35 (4) (23–54) |
Mean LVOTG (mmHg) | 25 (5) (1–39) | 21 (4) (1–36) | 22 (5) (1–112) |
Mean left atrium (mm) | 43 (2) (33–49) | 45 (4) (36–67) | 46 (4) (32–63) |
Implantable cardioverter-defibrillator | 0 (0%) | 0 (0%) | 0 (0%) |
Myectomy | 0 (0%) | 1 (2.4%) | 0 (0%) |
Pacemaker | 1 (14.3%) | 1 (2.4%) | 0 (0%) |